\sammlung{15676 Genexpression und Onkogene}
15391 Zoltan Szallasi: Gene expression patterns and cancer.\par
Nature Biotechn. 16 (1998), 1292-1293.\\

15445 Tanya Gottlieb/Moshe Oren: p53 in growth control and neoplasia.
Biochim. Biophys. Acta 1287 (1996), 77-102.\\

15440 Karen Vousden: Activation of the p53 tumor suppressor protein.
Biochi. Biophys. Atta 1602 (2002), 47-59.\\

15442 Michaela Herzig/Gerhard Christofori: Recent advances in cancer
research - mouse models of tumorigenesis.\par
Biochim. Biophys. Acta 1602 (2002), 97-113.\\

15166 Martin Tonko/Michael Aus''erlechner/David Bernhard/Arno
Helmberg/Reinhard Kofler: Gene expression profiles of proliferating
vs. G1/G0 arrested human leukemia cells suggest a mechanism for
glucocorticoid-induced apoptosis. FASEB J. 15 (2001), 693-699.\\

15446 Jerald Radich: The promise of gene expression analysis in
hematopoietic malignancies. Biochim.\par Biophys. Acta 1602 (2002), 88-95.\\

15412 Kristina Cole/David Krizman/Michael Emmert-Buck: The genetics of
cancer - a 3D model.\par Nature Genetics Suppl. January 1999, 38-41.\\

11584 Marcia Barinaga: Death by dozens of cuts.\par
Science 3 April 1998, 32-34.\\

15447 James De Gregori: The genetics of the E2F family of
transcription factors - shared functions and unique roles.\par
Biochim. Biophys. Acta 1602 (2002), 131-150.\\

15441 Werner Lutz/Javier Leon/Martin Eilers: Contributions of myc to
tumorigenesis. Biochim. Biophys. Acta 1602 (2002), 61-71.\\

15443 Jacqueline Jacobs/Maarten van Lohuizen: Polycomb expression -
from cellular memory to cellular proliferation and cancer.\par
Biochim. Biophys. Acta 1602 (2002), 151-161.\\

15382 Sonja Nauenburg/Werner Zwerschke/Pidder Jansen-Du''rr: Induction
of apoptosis in cervical carcinoma cells by peptide aptamers that bind
to the HPV-16 E7 oncoprotein.\par FASEB J. 19 January 2001, 592-594.\\

14429 C. Bajdik a.o.: A computer model to simulate family history of
breast/ovarian cancer in BRCA1 mutation carriers.\par
Math. Biosci. 171 (2001), 99-111.\\

15392 Tatsuya Akutsu/Satoru Miyano: Selecting informative genes
for cancer classification using gene expression data.\par
Internet ca. 2001, 5p.\\

14052 Anthony Dear/Robert Medcalf: The novel anti-tumour agent
oxamflatin differentially regulates urokinase and plasminogen
activator inhibitor type 2 expression and inhibits urokinase-mediated
proteolytic ativity. Biochim. Biophysica Acta 1492 (2000), 15-22.\\

13996 Michel Aguet: [Presentation. Aguet is the director of ISREC.]
Internet 2000, 5p.\\

\end{tabular}